| Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy JS Bajaj, NS Betrapally, PB Hylemon, DM Heuman, K Daita, MB White, ... Hepatology 62 (4), 1260-1271, 2015 | 322 | 2015 |
| Impaired gut-liver-brain axis in patients with cirrhosis V Ahluwalia, NS Betrapally, PB Hylemon, MB White, PM Gillevet, ... Scientific reports 6 (1), 26800, 2016 | 211 | 2016 |
| Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis C Acharya, NS Betrapally, PM Gillevet, RK Sterling, H Akbarali, MB White, ... Alimentary pharmacology & therapeutics 45 (2), 319-331, 2017 | 161 | 2017 |
| Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function JS Bajaj, IJ Cox, NS Betrapally, DM Heuman, ML Schubert, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (10 …, 2014 | 148 | 2014 |
| Changes in the intestinal microbiome and alcoholic and nonalcoholic liver diseases: causes or effects? NS Betrapally, PM Gillevet, JS Bajaj Gastroenterology 150 (8), 1745-1755. e3, 2016 | 128 | 2016 |
| Gut microbiome and liver disease NS Betrapally, PM Gillevet, JS Bajaj Translational Research 179, 49-59, 2017 | 121 | 2017 |
| Decompensated cirrhosis and microbiome interpretation JS Bajaj, NS Betrapally, PM Gillevet Nature 525 (7569), E1-E2, 2015 | 120 | 2015 |
| Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice DJ Kang, NS Betrapally, SA Ghosh, RB Sartor, PB Hylemon, PM Gillevet, ... Hepatology 64 (4), 1232-1248, 2016 | 104 | 2016 |
| Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition DJ Kang, G Kakiyama, NS Betrapally, J Herzog, H Nittono, PB Hylemon, ... Clinical and translational gastroenterology 7 (8), e187, 2016 | 90 | 2016 |
| Gut microbiota alterations can predict hospitalizations in cirrhosis independent of diabetes mellitus JS Bajaj, NS Betrapally, PB Hylemon, LR Thacker, K Daita, DJ Kang, ... Scientific reports 5 (1), 18559, 2015 | 85 | 2015 |
| HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients JS Bajaj, RK Sterling, NS Betrapally, DE Nixon, M Fuchs, K Daita, ... Alimentary pharmacology & therapeutics 44 (6), 638-643, 2016 | 64 | 2016 |
| Whole-gene analysis of inter-genogroup reassortant rotaviruses from the Dominican Republic: Emergence of equine-like G3 strains and evidence of their reassortment with locally … MDB Katz, Eric M., Mathew D. Esona, Naga S. Betrapally, A. Lucia, Yenny R ... Virology 534, 114-131, 2019 | 42 | 2019 |
| Gut microbial composition can differentially regulate bile acid synthesis in humanized mice DJ Kang, PB Hylemon, PM Gillevet, RB Sartor, NS Betrapally, ... Hepatology communications 1 (1), 61-70, 2017 | 41 | 2017 |
| Metagenomic sequencing generates the whole genomes of porcine rotavirus A, C, and H from the United States JJA Hull, M Qi, AM Montmayeur, D Kumar, DE Velasquez, SS Moon, ... PLoS One 15 (12), e0244498, 2020 | 17 | 2020 |
| Comparative genomic analysis of genogroup 1 and genogroup 2 rotaviruses circulating in seven US cities, 2014–2016 MD Esona, R Gautam, E Katz, J Jaime, ML Ward, ME Wikswo, ... Virus evolution 7 (1), veab023, 2021 | 15 | 2021 |
| Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota R Thanissery, MR McLaren, A Rivera, AD Reed, NS Betrapally, T Burdette, ... Anaerobe 66, 102279, 2020 | 8 | 2020 |
| Whole gene analysis of a genotype G29P [6] human rotavirus strain identified in Central African Republic V Banga-Mingo, MD Esona, NS Betrapally, R Gautam, J Jaimes, E Katz, ... BMC Research Notes 14 (1), 218, 2021 | 2 | 2021 |
| Distribution of rotavirus genotypes in the postvaccine introduction era in Ashaiman, Greater Accra Region, Ghana, 2014‐2016 V Letsa, S Damanka, F Dennis, B Lartey, GE Armah, N Betrapally, ... Journal of Medical Virology 91 (11), 2025-2028, 2019 | 2 | 2019 |
| Characterization of C. difficile strains isolated from companion animals and the associated changes in the host fecal microbiota R Thanissery, MR McLaren, A Rivera, AD Reed, NS Betrapally, T Burdette, ... bioRxiv, 822577, 2019 | 2 | 2019 |
| Innovative and emerging technologies in GI physiology and disease: systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota … JS Bajaj, IJ Cox, NS Betrapally, DM Heuman, ML Schubert, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (10 …, 2014 | 2 | 2014 |
Patrick GillevetProfessor and Director, Microbiome Analysis Center, George Mason UniversityVerified email at gmu.edu
